Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neuroactive Steroid Levels in a transgenic rat model of CMT1A Neuropathy.

Journal of molecular neuroscience : MN - 1 Mar 2008

Caruso Donatella, Scurati Samuele, Roglio Ilaria, Nobbio Lucilla, Schenone Angelo, Melcangi Roberto C

Abstract excerpt

Charcot-Marie-Tooth type 1A (CMT1A) represents 80% of all the demyelinating hereditary motor and sensory neuropathies. As recently suggested, neuroactive steroids may have a role in a therapeutic strategy for peripheral neuropathies, including CMT1A. To this aim, an accurate qualitative and quantitative analysis of neuroactive steroid levels in this disease could be extremely important to define effective...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Charcot-Marie-Tooth Disease
Share to Chromatography, Liquid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to gamma-Aminobutyric Acid

Share to Myelin Proteins

Share to Peripheral Nerves

Share to Receptors, GABA-A

Share to Sciatic Nerve

Share to Steroids

Source

Identifiers

PMID: 18193358
DOI: 10.1007/s12031-007-9029-3

Genes

PMP22

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neuroactive Steroid Levels in a transgenic rat model of CMT1A Neuropathy.PMID 18193358Read ↗

Natural history and treatment of peripheral inherited neuropathies.Semantic proximity Read ↗

A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients.Semantic proximity Read ↗

Animal models of inherited neuropathiesSemantic proximity Read ↗

Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A)Semantic proximity Read ↗

Central Alteration in Peripheral Neuropathy of Trembler-J Mice: Hippocampal pmp22 Expression and Behavioral Profile in Anxiety Tests.Semantic proximity Read ↗

Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathySemantic proximity Read ↗

Expanding the therapeutic potential of neuro(active)steroids: a promising strategy for hyperdopaminergic behavioral phenotypes.Semantic proximity Read ↗

The Selective Glucocorticoid Receptor Modulator CORT125329 Decreases Neuroinflammation and Gliosis and Enhances Myelination in the Wobbler Model of Amyotrophic Lateral SclerosisSemantic proximity Read ↗

Translocator protein and steroidogenesisSemantic proximity Read ↗

The 11β-hydroxysteroid dehydrogenase type 1 inhibitor SPI-62 prevents morbidity in a mouse model of Cushing’s syndromeSemantic proximity Read ↗

Curcumin-cyclodextrin/cellulose nanocrystals improve the phenotype of Charcot-Marie-Tooth-1A transgenic rats through the reduction of oxidative stress.Semantic proximity Read ↗

Sex differences in the pituitary transforming growth factor-β1 system: studies in a model of resistant prolactinomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.